🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Perfusion Index for Predicting Diabetic Ketoacidosis Severity in the Emergency Department

Recruitingn/aAges 18 Years - anyAllAnkara Etlik City Hospital
NCT07820371 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational cohort study will evaluate whether the perfusion index measured at emergency department admission is associated with the severity of diabetic ketoacidosis in adults. The study will include 140 patients aged 18 years or older who are diagnosed with diabetic ketoacidosis in the emergency department. The perfusion index will be measured using pulse oximetry. Serum lactate measured as part of routine clinical care will also be recorded, and the lactate-to-perfusion index ratio will be calculated. The ability of the perfusion index, serum lactate, and the lactate-to-perfusion index ratio to predict diabetic ketoacidosis severity will be compared. Their associations with time to diabetic ketoacidosis resolution, intensive care unit admission, hospital and intensive care unit length of stay, mechanical ventilation, vasopressor use, and in-hospital mortality will

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 18 years or older. 2. Diagnosis of diabetic ketoacidosis in the emergency department. 3. Ability to obtain perfusion index and serum lactate measurements during the initial assessment after admission. 4. Provision of written informed consent by the patient or, when necessary, the patient's legally authorized representative. Exclusion Criteria: 1. Pregnancy. 2. Trauma, major bleeding, or hemorrhagic shock. 3. Cardiac arrest. 4. Conditions that may prevent reliable perfusion index measurement, including advanced hypothermia, severe peripheral arterial disease, or amputation, burns, severe edema, or deformity at the measurement site. 5. Advanced chronic liver failure. 6. End-stage renal disease or dialysis treatment. 7. Inability to obtain the essential study variables or presence of missing data. 8. Refusal to participate in the study. 9. Repeat emergency department presentation by the same participant; only the first presentation will be included.
💊

What it tests

  • Not listed
📍

Where

2 sites
Ankara Etlik City Hospital, Department of Emergency Medicine
Ankara, Turkey (Türkiye)
Ankara Etlik City Hospital, Department of Emergency Medicine
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy